157 related articles for article (PubMed ID: 199758)
1. Probucol (Lorelco) in treatment of hyperlipemia.
Murphy BF
JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
[TBL] [Abstract][Full Text] [Related]
2. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
[TBL] [Abstract][Full Text] [Related]
3. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.
Buckley MM; Goa KL; Price AH; Brogden RN
Drugs; 1989 Jun; 37(6):761-800. PubMed ID: 2667936
[TBL] [Abstract][Full Text] [Related]
4. Probucol: a new cholesterol-lowering drug effective in patients with type II hyperlipoproteinemia.
Salel AF; Zelis R; Sodhi HS; Price J; Mason DT
Clin Pharmacol Ther; 1976 Dec; 20(6):690-4. PubMed ID: 186224
[TBL] [Abstract][Full Text] [Related]
5. Effect of probucol in hyperlipidemic patients during two years of administration.
Parsons WB
Am Heart J; 1978 Aug; 96(2):213-7. PubMed ID: 354360
[TBL] [Abstract][Full Text] [Related]
6. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
Cortese C; Marenah CB; Miller NE; Lewis B
Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
[TBL] [Abstract][Full Text] [Related]
7. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome.
Iida H; Izumino K; Asaka M; Fujita M; Nishino A; Sasayama S
Nephron; 1987; 47(4):280-3. PubMed ID: 3696330
[TBL] [Abstract][Full Text] [Related]
8. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.
Mellies MJ; Gartside PS; Glatfelter L; Vink P; Guy G; Schonfeld G; Glueck CJ
Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291
[No Abstract] [Full Text] [Related]
9. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
10. Probucol in hypercholesterolemia. A double blind study.
Riesen WF; Keller M; Mordasini R
Atherosclerosis; 1980 Jun; 36(2):201-7. PubMed ID: 7406949
[TBL] [Abstract][Full Text] [Related]
11. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
[TBL] [Abstract][Full Text] [Related]
12. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
Tikkanen MJ; Helve E; Nikkilä EA
Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
[TBL] [Abstract][Full Text] [Related]
13. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
Helve E; Tikkanen MJ
Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
Miettinen TA; Toivonen I
Postgrad Med J; 1975; 51(8):suppl 71-5. PubMed ID: 215985
[TBL] [Abstract][Full Text] [Related]
15. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
[TBL] [Abstract][Full Text] [Related]
16. [Probucol in the treatment of hyperlipidemias].
Feder D; Langer AL; Alexandrino E; Medeiros S; Lotto M; Valente O
Arq Bras Cardiol; 1986 Feb; 46(2):77-80. PubMed ID: 3827649
[No Abstract] [Full Text] [Related]
17. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
18. [Clinical research on the hypolipidemic action of a probucol preparation].
Naumova R; Kerekovska M; Goranov I; Balabanski L
Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
[TBL] [Abstract][Full Text] [Related]
19. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
[TBL] [Abstract][Full Text] [Related]
20. Effects of probucol on lipoprotein protein kinetics.
Nestel PJ
Artery; 1982; 10(2):95-8. PubMed ID: 7092582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
